≥99% HPLCPre-filled pen

AC-KPV-NH2

Name: AC-KPV-NH2
Brand: Dripfy
Availability: InStock

What it is?

AC-KPV-NH2 is the smallest biologically active fragment of α-MSH (alpha-melanocyte stimulating hormone), studied for its role in inflammation-modulating signalling. It is positioned for protocols where inflammatory tone, immune balance, and tissue-calming pathways are primary endpoints—particularly in skin and barrier-focused frameworks.

Dripfy Advantage

Receptor engagement: Interacts with melanocortin receptors implicated in inflammation-control signalling pathways.
Cytokine modulation: Positioned to reduce pro-inflammatory cytokine signalling, supporting a more regulated inflammatory microenvironment.
Barrier and tissue-calming orientation: Frequently positioned for tissue-calming endpoints where barrier integrity and local inflammation are tracked.
Immune balance support: Often framed as supporting immune equilibrium—modulating excessive inflammatory signalling rather than blunt suppression.

Clinical Applications & Therapeutic Potential

Inflammation-control frameworks: Potential support for improved inflammatory marker profiles in targeted tissue models (context-dependent).
Inflammatory skin-condition endpoints: Positioned for skin-calming and barrier-support endpoints where inflammation is a central driver.
Immune equilibrium outcomes: Potential support for balanced immune signalling and tolerance–vigilance stability markers.
Localised protocol utility: Often selected for protocols focused on local inflammation control and tissue comfort endpoints.

Composition & Formulation

Peptide Content: 10 mg KPV peptide
Vehicle: Proprietary pH-balanced buffer solution
Delivery System: Pre-filled, multi-dose, closed-system pen
Total Volume: 3 mL
Purity: ≥99% by HPLC/MS

€413

Order by email

Submit an enquiry and we arrange the consultation, physician review and shipping. Physician recommendation required; not medical advice.

Purity: ≥99%
Form: Pre-filled pen
Download Certificate of Analysis: Certificate of Analysis available on request

Important medical notice

A physician recommendation is mandatory before use.
The information on this website is educational only and is not medical advice, diagnosis, or treatment.
Always consult a qualified physician before starting any peptide.
Dosing is individualised and determined by your treating physician.

Peptide Practice Guide

Each card summarises what the peptide is studied for and its evidence strength. It is not a recommendation. Dosing and suitability are decided by your physician.

AC-KPV-NH2

Investigational α-MSH-derived tripeptide (melanocortin-linked, anti-inflammatory) · Pre-filled pen

D· Preliminary evidence

AC-KPV-NH2 is the smallest active tripeptide fragment of α-MSH. In laboratory and animal models it is associated with engaging melanocortin-linked pathways and dampening pro-inflammatory cytokine signalling, which is linked to a calmer inflammatory microenvironment in skin and barrier tissue. Its relevance to human tissue healing is studied but not established.

Studied use areas

Inflammatory skin conditions (research context)
Gut and barrier-tissue inflammation (research context)
General tissue-calming and inflammation-balance endpoints
Support of the wound microenvironment (studied)

Safety & status

Investigational and not an approved medicine; human safety data are limited
Allergic or hypersensitivity reactions cannot be excluded
Use only under qualified physician oversight with appropriate screening

⚕ Clinical note: This card is educational and is not medical advice. AC-KPV-NH2 is investigational; any use must be individualised and supervised by a treating physician.

Evidence: Investigational — mainly preclinical anti-inflammatory data, no approved human indication · References: preclinical anti-inflammatory and melanocortin-pathway research; peer-reviewed skin- and gut-barrier literature; EMA/MHRA product-status information on unapproved peptides